150～250μm PVA颗粒栓塞治疗子宫肌瘤的临床价值  

The Clinical Value of 150～250μm PVA Embolotherapy for Leiomyoma

作　　者：袁亮[1] 李玉伟[1] 张富强[1] 斯光晏[1] 李云辉[1] 

机构地区：[1]泸州医学院附属医院介入病房,四川646000

出　　处：《当代医学》2009年第5期64-66,共3页Contemporary Medicine

摘　　要：目的探讨150～250μmPVA颗粒经子宫动脉栓塞术(UAE)治疗子宫肌瘤的临床价值。方法选择46例症状性子宫肌瘤行UAE治疗,实验组24例患者用150～250μmPVA颗粒栓塞,对照组22例患者用350～500μmPVA颗粒栓塞,随访两组患者术后疗效:①比较术前及术后月经量及疼痛的变化;②比较术前及术后6月子宫肌瘤体积的变化。结果所有患者术后月经量及疼痛均有好转;术后6月子宫肌瘤体积缩少明显,但实验组肌瘤体积缩小更显著。结论两种不同直径的PVA颗粒经UAE治疗子宫肌瘤均安全有效,但150～250μmPVA颗粒疗效更好,应予以推广。Objective Approaching the therapeutic effect of 150-250 μm PVA in embolotherapy for leiomyoma. Methods 46 symptomatic leiomyomas treated with UAE were enrolled in the study, the experiment group with 24 patients embolized by 150-250 μm PVA, the control group with 22 patients embolized by 350-500 μmPVA. The postoperative curative effect were evaluated with following items： （1）comparing variation of menstrual blood volume and pain between preoperation and postoperation;（2）comparing volumetric variation of leiomyomas between preoperation and postoperation at 6 months. Results The menstrual blood volume was reduced and pain was relieved in all patients during follow up. The obvious reduction in leiomyoma volume was found at 6 months, and the experiment group had better efficacy with more reduction. Conclusion It is safe and effective to treat hysteromyoma by uterine arterial embolization（UAE） with different size of polyvinyl alcohols, and 150-250 μm PVA has better result.

关 键 词：子宫肌瘤 栓塞 聚乙烯醇 

分 类 号：R737.33[医药卫生—肿瘤] R735.705[医药卫生—临床医学]